Market3 Monaten ago
BNTX Shares Rise 10%, EU Begins Review of BioNTech-Pfizer Vaccine
The start of the review process of the BioNTech-Pfizer vaccine has triggered investors to bet more on BNTX stock. The European Union’s European Medicines Agency (EMA)...
Neueste Kommentare